Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

USANA growth

This article was originally published in The Tan Sheet

Executive Summary

Q1 net earnings of $3.6 mil. are more than triple income recorded in the first quarter of 2001, reflecting international expansion, "combined with improved operating efficiencies," supplement direct-marketer explains in April 15 analysts call. Sales for USANA Health Sciences grew 42.8 % to $40.9 mil. in the period, led by increases in customers, sales associates. CFO Gilbert Fuller projects sales of $42 mil. in Q2, $170 mil. for FY 2003. Bank debt eliminated in Q1 for first time in four years, Fuller adds...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS095383

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel